MA 05.01 Integrating INDEL Mutations into Neoantigen Prediction in Lung Cancer: Developing Personalized Cancer Vaccines

Y. Lou; Y. Asmann; M. Thomas; K. Knutson

首页> 外文期刊>Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer >MA 05.01 Integrating INDEL Mutations into Neoantigen Prediction in Lung Cancer: Developing Personalized Cancer Vaccines

【24h】

MA 05.01 Integrating INDEL Mutations into Neoantigen Prediction in Lung Cancer: Developing Personalized Cancer Vaccines

机译：将吲哚突变整合到肺癌中的新南根预测中：开发个性化癌症疫苗

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 |2017年第11期|共2页
作者
Y. Lou; Y. Asmann; M. Thomas; K. Knutson;
展开▼
作者单位

Hematology and Oncology Mayo Clinic;

Health Science Research Mayo Clinic;

Thoracic Surgery Mayo Clinic;

Cancer Basic Science Mayo Clinic;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. MA 05.01 Integrating INDEL Mutations into Neoantigen Prediction in Lung Cancer: Developing Personalized Cancer Vaccines [J] . Y. Lou, Y. Asmann, M. Thomas, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2017,第11期

机译：将吲哚突变整合到肺癌中的新南根预测中：开发个性化癌症疫苗
2. Neoantigen Tracking: Tracking Neoantigens by Personalized Circulating Tumor DNA Sequencing during Checkpoint Blockade Immunotherapy in Non‐Small Cell Lung Cancer (Adv. Sci. 9/2020) [J] . Qingzhu Jia, Luting Chiu, Shuangxiu Wu, Advanced Science . 2020,第9期

机译：NeoAntigen跟踪：在非小细胞肺癌检查点延迟免疫疗法中，通过个性化循环肿瘤DNA测序跟踪NeoAntigens（ADV。SCI。9/2020）
3. A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer [J] . Ott Patrick A., Hu-Lieskovan Siwen, Chmielowski Bartosz, Cell . 2020,第2期

机译：个性化新洲治疗的A相IB试验加上先进黑素瘤，非小细胞肺癌或膀胱癌患者的抗PD-1
4. Four Layers Image Representation for Prediction of Lung Cancer Genetic Mutations Based on 2DPCA [C] . Moataz M. Abdelwahab, Shimaa A. Abdelrahman IEEE Pulsed Power Conference . 2017

机译：基于2DPCA的肺癌遗传突变预测的四层图像表示
5. Pharmacology Profiles of ALK and FLT3 Kinase Inhibitors against Non-Small-Cell Lung Cancer Cells and Acute Myeloid Leukemia Cells with Cancer Driver Mutations [D] . 森政道 2019

机译：ALK和FLT3激酶抑制剂对非小细胞肺癌细胞和急性髓系白血病细胞的癌症驱动突变的药理作用
6. Is It Possible to Develop Cancer Vaccines to Neoantigens What Are the Major Challenges and How Can These Be Overcome?: Neoantigens as Vaccine Targets for Cancer [O] . Haydn T. Kissick 2018

机译：是否有可能将癌症疫苗发展到新稻草原主要挑战是什么以及如何克服这些挑战？：Neoantigens作为癌症的疫苗目标
7. Personalized immunotherapy for non-small cell lung cancer through identification of tumor-specific mutations by next generation sequencing and adoptive transfer of tumor infiltrating lymphocytes that recognize neoantigens [O] . Ken-ichi Hanada, Christopher Chow, Raul Hoyos, 2015

机译：非小细胞肺癌的个性化免疫疗法，通过下一代测序鉴定肿瘤特异性突变和识别新抗原的肿瘤浸润淋巴细胞的过继转移

MA 05.01 Integrating INDEL Mutations into Neoantigen Prediction in Lung Cancer: Developing Personalized Cancer Vaccines

著录项

引文网络

相似文献

相关主题

期刊订阅